MediciNova (NASDAQ: MNOV)
MediciNova Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
MediciNova Company Info
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
News & Analysis
3 Top Biotech Stocks to Buy Right Now
These three biotech stocks recently had positive news coming out of phase 2 trials, making them good choices for growth-oriented investors.
Why MediciNova Stock Skyrocketed Today
The biotech announced a major new development partnership.
Here's Why MediciNova Is Soaring Today
The small-cap pharmaceutical company announced a collaboration to develop a coronavirus vaccine.
Why Limelight Networks, MediciNova, and Commvault Systems Jumped Today
Find out how these stocks survived a horrible day for the market.
Here's Why MediciNova Jumped as Much as 26.2% Today
The biopharma stopped a clinical trial early after a drug candidate showed impressive efficacy.
Here's Why MediciNova, Inc. Stock Is Sliding Today
Lower-than-expected pricing for a secondary offering just took the shine off recently announced trial data.
5 of Last Week's Biggest Winners
These five stocks moved higher this past week.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.